You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
LH |
||
Geisinger Epic Procedure Code: LAB2608
Geisinger Epic ID: 6710
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Plasma or serum. | |
Preferred collection container: |
||
Specimen required: |
2 mL of serum or plasma; minimum 0.5 mL. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow serum to clot. Centrifuge to separate serum or plasma within 2 hours of collection. | |
Transport temperature: |
Refrigerated (preferred) or frozen. | |
Specimen stability: |
Refrigerated: 14 days. Frozen: 6 months. | |
Rejection criteria: |
Stability limits exceeded. | |
TEST DETAILS |
||
Reference interval: |
FEMALES Follicular phase: 2.4-12.6 mIU/mL Ovulation phase: 14.0-95.6 mIU/mL Luteal phase: 1.0-11.4 mIU/mL Postmenopausal: 7.7-58.5 mIU/mL MALES: 1.7-8.6 mIU/mL |
|
Additional information: |
It is well known that heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous high values can be observed. Additional information may be required for diagnosis. | |
CPT code(s): |
83002 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Luteinizing hormone. | |
Methodology: |
Chemiluminescence Immunoassay |
|
Synonyms: |
LU, Lutropin LH, Luteinizing hormone
|
|
Clinical significance: |
The determination of LH in conjunction with FSH is utilized for the following indications: congenital diseases with chromosome aberrations (e.g., Turner's syndrome), polycystic ovaries (PCO), clarifying the causes of amenorrhea, menopausal syndrome and suspected Leydig cell insufficiency. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |